Mitochondria and Cancer
From Basic Science to Clinical Applications – Understanding Pathogenesis, Therapy Resistance, and Disease Relapse
- 1st Edition - March 1, 2026
- Latest edition
- Editors: Farzad Taghizadeh-Hesary, Sumel Ashique, Babak Behnam, Maria Vliora
- Language: English
Mitochondria and Cancer: From Basic Science to Clinical Applications—Understanding Pathogenesis, Therapy Resistance, and Disease Relapse offers comprehensive perspectives… Read more
Mitochondria and Cancer: From Basic Science to Clinical Applications—Understanding Pathogenesis, Therapy Resistance, and Disease Relapse offers comprehensive perspectives about the role of mitochondria in cancer biology and treatment. This book integrates fundamental scientific knowledge with clinical relevance, presenting recent findings that will engage oncology researchers and provide valuable recommendations for cancer prevention and prognosis. In response to the rising global cancer incidence, this book serves as a comprehensive guide to mitochondrial metabolism in oncology, furthering cancer study and management. It explores a wide range of topics that highlight the multifaceted role of mitochondria in cancer, including tumor microenvironment, cancer stem cells, microbiota, resistance mechanisms, mitochondria-enhancing strategies, and targeted therapies. It includes technical details, research findings, and discussions on the implications of mitochondrial research in cancer treatment and management. Its distinguishing aspects include its comprehensive coverage and diverse perspectives from global experts, providing a well-rounded view of current research.
• Delivers an in-depth analysis of how mitochondrial alterations contribute to cancer formation, disease progression, and resistance to conventional and targeted therapies
• Presents comprehensive insights into the dynamic interactions between mitochondria in cancer cells, tumor microenvironment, and microbiota, highlighting their collective influence on cancer progression and therapeutic outcomes
• Combines fundamental scientific knowledge with clinical relevance, covering a wide array of topics from mitochondrial metabolism to innovative therapeutic strategies
• Presents comprehensive insights into the dynamic interactions between mitochondria in cancer cells, tumor microenvironment, and microbiota, highlighting their collective influence on cancer progression and therapeutic outcomes
• Combines fundamental scientific knowledge with clinical relevance, covering a wide array of topics from mitochondrial metabolism to innovative therapeutic strategies
Researchers in oncology, molecular biology, clinical oncology, and biomedical research
1. Mitochondria: Origin, Structure, and Function
2. Mitochondrial Metabolism and Trafficking in Cancer
3. Mitochondrial Genome and Cancer
4. Mitochondrial-nuclear Crosstalk and Its Role in Cancer
5. Mitochondria and Tumor Microenvironment
6. Mitochondria and Cancer Stem Cells
7. Mitochondria, Exosome, Cancer
8. Mitochondria, Microbiota, Cancer
9. MiRNAs and Their Impacts on Cancer Cell’s Mitochondria
10. Mitochondria and Cancer Prevention
11. Mitochondria and Cancer Diagnosis
12. Mitochondrial Metabolism as a Prognostic Biomarker (Mitochondria and Cancer Progression)
13. Mitochondria, Tumor Microenvironment, and Radioresistance
14. Mitochondria and Resistance to Chemotherapy
15. Mitochondria and Resistance to Targeted Therapies
16. Mitochondria and Resistance to Immunotherapy
17. Mitochondria Enhancing Strategies in Cancer
18. Advances in Targeted Anti-mitochondrial Therapies
19. Applying Magnetic Fields to Target Mitochondria
20. what the Artificial Intelligence (AI) Proposes for the Mitochondria Role in Cancer
2. Mitochondrial Metabolism and Trafficking in Cancer
3. Mitochondrial Genome and Cancer
4. Mitochondrial-nuclear Crosstalk and Its Role in Cancer
5. Mitochondria and Tumor Microenvironment
6. Mitochondria and Cancer Stem Cells
7. Mitochondria, Exosome, Cancer
8. Mitochondria, Microbiota, Cancer
9. MiRNAs and Their Impacts on Cancer Cell’s Mitochondria
10. Mitochondria and Cancer Prevention
11. Mitochondria and Cancer Diagnosis
12. Mitochondrial Metabolism as a Prognostic Biomarker (Mitochondria and Cancer Progression)
13. Mitochondria, Tumor Microenvironment, and Radioresistance
14. Mitochondria and Resistance to Chemotherapy
15. Mitochondria and Resistance to Targeted Therapies
16. Mitochondria and Resistance to Immunotherapy
17. Mitochondria Enhancing Strategies in Cancer
18. Advances in Targeted Anti-mitochondrial Therapies
19. Applying Magnetic Fields to Target Mitochondria
20. what the Artificial Intelligence (AI) Proposes for the Mitochondria Role in Cancer
- Edition: 1
- Latest edition
- Published: March 1, 2026
- Language: English
FT
Farzad Taghizadeh-Hesary
Dr. Farzad Taghizadeh-Hesary is an Associate Professor at the Research Institute for Environment and Sustainability (TRIES) at Tokai University in Tokyo, Japan, and Vice-President of the International Society for Energy Transition Studies (ISETS). He also serves as Chief Economist at Climate Finance Asia and Editor-in-Chief of the Journal of Environmental Assessment Policy and Management. In 2024-5, he led a project to draft Just Transition guidelines for banks, commissioned by a group of leading global banks, international organizations, and philanthropic foundations. In 2023, he was awarded the Medal and Commendation for Science and Technology by Japan's Minister of Education for his contributions to renewable energy finance. Recognized as a Highly Cited Researcher by Clarivate Analytics, Dr. Taghizadeh-Hesary has authored over 400 academic papers and book chapters, as well as 30 books, primarily focusing on energy transition, policy, finance, and sustainability. He holds a Ph.D. in economics from Keio University in Japan.
Affiliations and expertise
Breast Cancer Research Center, Iran University of Medical Sciences, Tehran, IranSA
Sumel Ashique
Sumel Ashique has been working as an assistant professor at Bengal College of Pharmaceutical Sciences & Research, Durgapur 713212, West Bengal, India, West Bengal, India. He has 3.5 years of teaching experience. He has achieved 70+ publications of International and national accredited reputed journals (Scopus, UGC). He has knowledge in drug delivery, nanotechnology and targeted treatment strategy. He has also 6 granted patents from IP and Australia & 20 book chapters have been submitted to well-known publishers like Springer, Elsevier, Bentham and Taylor & Francis. Currently he is editing 13 books under CRC Press, Taylor & Francis, Springer and Wiley.
Affiliations and expertise
Asst. Professor, Department of Pharmaceutical Technology, Bharat Technology, Uluberia, West Bengal, IndiaBB
Babak Behnam
Dr. Babak Behnam has completed his PhD degree at the University College London (UCL) in Human Genetics. Then he served as postdoctoral research fellow at the University of Michigan School of Medicine and University of Central Florida (UCF). He joined the Undiagnosed Disease Program (UDP) at NIH while doing an American Board of Medical Genetics and Genomic in clinical biochemical laboratory genetics at NHGRI, NIH. He joined NSF International as a clinical research organization. Dr. Behnam has published more than 70 peer-reviewed papers and has nine patents to his name throughout his career; also, has served as an Editorial Board Member of several scientific journals. He has enthusiasm in translational research, neuroscience & neurogenetics, and biochemical & molecular mechanisms utilizing advanced technological improvements in biochemical genetics, genomics, and NGS platforms. Also, he has an experience and interest in clinical research, and regulatory and scientific analysis of clinical trials.
Affiliations and expertise
• American University, College of Arts and Sciences, Department of Biology, Washington, DC, USA • The Floret Center, Advanced Genomics & Bioinformatics Research Center, Lagos, NigeriaMV
Maria Vliora
Dr. Vliora Maria is a Molecular Biologist with extensive background in molecular biology and integrative physiology. She has previously studied mutations of immunoglobulins in Chronic Lymphocytic Leukemia patients, and ALK mutations and downstream signaling in Neuroblastoma. Dr. Vliora has a PhD in Biomedical Research from University of Thessaly, Greece and University of Brescia, Italy. She has worked on the development of biocompatible/biodegradable bioscaffolds for targeting adipose tissue as well as on potential nanomedical treatments for brain tumors as well as blood malignancies. Her research work is now focusing on environmental influences that can affect human health and on the use of novel biodegradable bio-scaffolds for allografting adipose stem cells in humans. She collaborated with reputable organizations (WHO, ILO) on projects aiming to enhance human health and wellbeing. She now works as a Project Manager on EU funded projects.
Affiliations and expertise
FAME Laboratory, Department of Physical Education and Sport Science, University of Thessaly, Trikala, Greece